Obesity Drugs Are Getting Easier and Cheaper to Find
More apps, new markets and novel compounds will further ease access.
This article is for subscribers only.
Welcome back to Bloomberg’s Health Monitor, a weekly look at the boardroom decisions, scientific advances and policy fights shaping the future of medicine. Sign up now if you’re not already on the list.
The FDA’s chief medical officer Vinay Prasad will depart the agency for the second time next month, after once-unheard-of public clashes with drugmakers. Republican Senator Ron Johnson is looking into some rare disease denials that he tied to “bureaucratic idiocy.”